Ventaleon GmbH, a biotechnology company focusing on the development of inhaled treatments against viral infections, is pleased to congratulate Dr. Gerhard Scheuch, who has received the Juraj Ferin Award 2017 for his outstanding contributions to the International Society for Aerosols in Medicine (ISAM). The award was presented on June 4, 2017 at the 21st ISAM Congress in Santa Fe, New Mexico, USA.
Dr. Scheuch is an internationally recognized expert in pulmonary drug delivery, inhalation products as well as respiratory diseases and served as ISAM president from 2007 through 2013. Dr. Scheuch founded Ventaleon in 2012 and was CEO until stepping down earlier this year but will continue to serve as a member of the Supervisory Board of Ventaleon. He was founder and CEO of Activaero as well as of Inamed, both companies dedicated to developing inhalation technologies and therapies, and also served as chief scientific officer at Vectura group plc after
their acquisition of Activaero. He holds a PhD in physics from the Wolfgang Goethe University Frankfurt (Germany).